Eam Global Investors LLC Heron Therapeutics, Inc. Transaction History

Eam Global Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$22.03 - $32.01 $529,579 - $769,488	-24,039 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$30.0 - $40.85 $186,180 - $253,515	-6,206 Reduced 20.52%	24,039 $761,000
Q2 2018 Aug 03, 2018	SELL	$26.4 - $42.0 $991,478 - $1.58 Million	-37,556 Reduced 55.39%	30,245 $1.18 Million
Q1 2018 Jun 04, 2018	BUY	$18.43 - $28.8 $1.25 Million - $1.95 Million	67,801 New	67,801 $1.87 Million

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.